Dr. Larijani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-590-2169
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Dermatology, 2020 - 2021
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Dermatology, 2018 - 2019
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Dermatology, 2015 - 2018
- Main Line Health System/Lankenau Medical CenterInternship, Internal Medicine, 2015 - 2016
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2015
Certifications & Licensure
- PA State Medical License 2015 - 2024
- American Board of Dermatology Dermatology
- American Board of Dermatology Pediatric Dermatology
Publications & Presentations
PubMed
- 29 citationsLadarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironmentDaria Marley Kemp, Alyson Pidich, Mary Larijani, Rebecca Jonas, Elizabeth Lash
Oncotarget. 2017-01-24 - 16 citationsPrevalence and Types of Genital Lesions in Organ Transplant Recipients.Kumar S. Nadhan, Mary Larijani, James Abbott, Alden M. Doyle, Anthony W. Linfante
JAMA Dermatology. 2018-03-01 - 5 citationsAtopic dermatitis-like graft-versus-host disease treated with dupilumab.Mary Larijani, Diana Zarowin, Anne Wohlschlaeger, Marissa J Perman, James R Treat
Pediatric Dermatology. 2023-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: